 |
市場調查報告書
商品編碼
2130441
全球尿液檢查市場（至2031年）：按產品類型（耗材和設備）、檢測類型（妊娠檢測、尿沉渣檢測）、應用（尿道感染、糖尿病、慢性腎臟病）、技術（生物化學）、最終用戶（醫院）和地區分類Urinalysis Market by Product (Consumables,Instruments ), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031 |
||||||
價格
預計尿液檢查市場將從 2026 年的約 48.8 億美元成長到 2031 年的 71.6 億美元，預計成長率為 8.0%。
老年人口的快速成長導致糖尿病、腎臟疾病和肝臟疾病等老齡化相關疾病的發生率上升。這種日益加重的負擔推動了對定期診斷和監測測試的需求，包括代謝、血脂、腎功能和肝功能的評估。
| 調查範圍 | |
|---|---|
| 調查期 | 2026-2031 |
| 基準年 | 2025 |
| 預測期 | 2026-2031 |
| 單元 | 金額（美元） |
| 部分 | 產品、檢測類型、應用、技術、最終用戶 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲 |
尿液分析儀在篩檢和監測這些疾病方面發揮著至關重要的作用，這推動了其在醫院、診斷實驗室和其他醫療機構的廣泛應用。因此，老年人口的成長及其相關的疾病負擔預計將繼續成為尿液檢查市場的主要成長要素。
“按產品類別分類，到 2025 年，消耗品將佔據最大的市場佔有率。”
持續的需求和頻繁更換的耗材（例如試紙、試劑和品管）是其佔據主導市場佔有率的主要促進因素。此外，種類繁多的耗材能夠滿足各種尿液檢查需求，也促進了其廣泛應用。支援多種檢測參數的高效能試紙的研發也進一步推動了尿液檢查耗材的需求。
“從技術角度來看，到2025年，生物化學檢驗將佔據最大的市場佔有率。”
此細分市場佔有率較大，主要得益於試紙和免疫測定法在常規疾病篩檢、照護現場、家庭懷孕和免疫檢測檢測以及尿道感染感染、腎臟病、糖尿病和肝病早期檢測的廣泛應用。
此外，生物化學檢驗成本低廉、使用方便，在醫院、診斷實驗室和居家醫療機構中應用廣泛，慢性疾病和感染疾病日益加重，需要頻繁進行尿液檢查，以及試劑條和免疫檢測領域領先公司不斷進行的產品創新，也促進了這一領域的成長。
“亞太地區是尿液檢查市場成長最快的地區。”
這一成長主要得益於政府主導的疾病防治宣傳和早期檢測舉措的增加、人均收入的提高以及私營醫療基礎設施向農村和醫療服務不足地區的擴展。此外，全部區域新興和高成長市場的存在也促進了尿液檢查和診斷技術的應用。
本報告考察了全球尿液檢查市場，提供了概述、影響市場成長的各種因素分析、技術和專利趨勢、法律制度、案例研究、歷史和預測的市場規模、按細分市場/地區/主要國家/地區進行的詳細分析、競爭格局以及主要公司的概況。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 任務
- 未滿足的需求和閒置頻段
- 與相關市場和不同產業相關的跨領域機遇
- 一級/二級/三級公司的策略性舉措
第5章 產業趨勢
- 波特五力分析
- 總體經濟指標
- GDP趨勢與預測
- 供應鏈分析
- 價值鏈分析
- 生態系分析
- 價格分析
- 貿易分析
- 2026-2027 年主要會議和活動
- 影響客戶業務的趨勢/顛覆性因素
- 投資和資金籌措場景
- 2025年美國關稅對尿液檢查市場的影響
第6章：顧客趨勢與購買行為
- 決策流程
- 相關人員及購買評估標準
- 實施障礙和內部挑戰
- 各個終端用戶產業尚未滿足的需求
- 市場盈利
第7章 監管情勢與永續性
- 當地法規和合規性
- 對永續性的承諾
- 對永續性和監管政策舉措的影響
第8章：技術進步、人工智慧的影響、專利、創新與未來應用
- 主要新興技術
- 自動尿液分析儀
- 生化分析
- 互補技術
- 照護現場尿液分析儀
- 鄰近技術
- 多重PCR
- 技術/產品藍圖
- 專利分析
- 未來應用
- 人工智慧/生成式人工智慧對尿液檢查市場的影響
第9章：尿液檢查市場：依產品分類
- 消耗品
- 懷孕和生育力檢測套組
- 油尺（測試棒）
- 試劑
- 一次性產品
- 裝置
- 自動尿液分析儀
- 半自動尿液分析儀
- 照護現場尿液分析儀
第10章：尿液檢查市場：依應用領域分類
- 疾病篩檢
- 尿道感染
- 腎臟疾病
- 糖尿病
- 肝病
- 其他
- 妊娠和生育力檢查
第11章尿液檢查市場：依檢測類型分類
- 妊娠和生育力檢查
- 生物化學檢驗
- 臨床實驗室檢測
- 即時檢測
- 尿沉渣檢查
第12章尿液檢查市場：依技術分類
- 生化分析
- 流式細胞技術
- 數位顯微鏡
- 其他
第13章尿液檢查市場：依最終用戶分類
- 診斷檢測實驗室
- 醫院和診所
- 居家醫療
- 研究機構和研究機構
第14章尿液檢查市場：依地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東和非洲
- 阿拉伯聯合大公國
- 沙烏地阿拉伯
- 其他
第15章 競爭格局
- 主要參與企業的策略/優勢
- 收入分析
- 市佔率分析
- 企業估值矩陣：主要公司
- 公司估值矩陣：新創企業/中小企業
- 企業估值和財務指標
- 品牌/產品對比
- 競爭格局
第16章：公司簡介
- 大公司
- SIEMENS HEALTHINEERS AG
- F. HOFFMANN-LA ROCHE LTD
- SYSMEX CORPORATION
- DANAHER CORPORATION
- ABBOTT
- CARDINAL HEALTH, INC.
- WATERS CORPORATION
- THERMO FISHER SCIENTIFIC INC.
- BIO-RAD LABORATORIES, INC.
- QUIDELORTHO CORPORATION
- 其他公司
- ARKRAY, INC.
- ACON LABORATORIES, INC.
- 77 ELEKTRONIKA KFT.
- URIT MEDICAL ELECTRONIC CO., LTD.
- SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
- DIRUI INDUSTRIAL CO., LTD.
- BIOBASE GROUP
- ERBA MANNHEIM
- ALPHATEC SCIENTIFIC EIRL
- TECO DIAGNOSTICS
- ANALYTICON BIOTECHNOLOGIES GMBH
- HIVIS MEDICAL TECHNOLOGY CO., LTD.
- HIGH TECHNOLOGY, INC.
- AGAPPE DIAGNOSTICS LTD
- DIALAB GMBH
- QUANTIMETRIX
- BIOCARE CORPORATION
- RANDOX LABORATORIES LTD.
- PZ CORMAY SA
- YD DIAGNOSTICS
- CONTEC MEDICAL SYSTEMS CO., LTD.
- CLARITY DIAGNOSTICS, LLC
- BIOPANDA REAGENTS LTD.
- GENUINE BIOSYSTEM
第17章調查方法
第18章附錄
Product Code: MD 3259
The urinalysis market is valued at around USD 4.88 billion in 2026 and is expected to reach USD 7.16 billion by 2031, reflecting an 8.0% growth rate. The rapid expansion of the elderly population is contributing to a higher incidence of age-related conditions, including diabetes and kidney and liver disorders. The increasing burden of these diseases is driving demand for routine diagnostic and monitoring tests, including metabolic, lipid, and renal and liver function assessments.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Product, Test Type, Application, Technology, End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Urinalysis analyzers play an important role in screening and monitoring several such conditions, thereby supporting their adoption across hospitals, diagnostic laboratories, and other healthcare settings. Consequently, the growing geriatric population and associated disease burden are expected to remain significant drivers of urinalysis market growth.
"Consumables accounted for the largest share in the urinalysis market, by product, in 2025."
By product, the urinalysis market is segmented into consumables and instruments. The consumables segment accounts for the largest share of the urinalysis market. Recurring requirements and frequent replacement of consumables such as test strips, reagents, and controls are key drivers of its dominant share. Additionally, the availability of a wide range of consumables that cater to diverse urinalysis testing needs contributes to their widespread adoption. The development of advanced dipsticks with multiple test parameters further supports demand for urinalysis consumables.
"The biochemical assay segment accounted for the largest share in the urinalysis market, by technology, in 2025."
By technology, the urinalysis market is segmented into biochemical assays, flow cytometry, digital microscopy, and other technologies. In 2025, the biochemical assay segment led the urinalysis market. This segment's significant share is largely driven by the widespread use of reagent strips and immunoassay-based testing for routine disease screening, point-of-care diagnosis, home-based pregnancy and fertility testing, and preliminary detection of urinary tract infections, kidney diseases, diabetes, and liver diseases. Moreover, the low cost and ease of use of biochemical assays, their broad applicability across hospitals, diagnostic laboratories, and home care settings, the rising burden of chronic and infectious diseases requiring frequent urine testing, and continuous product innovation by key players in reagent strip and immunoassay formats are further contributing to the growth of this segment.
"Asia Pacific: Fastest-growing region in the urinalysis market."
The global urinalysis market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries. Asia Pacific is the fastest-growing regional market. This growth is driven by increasing government initiatives that promote disease awareness and early detection, rising per capita income, and the expansion of private healthcare infrastructure into rural and underserved areas. Additionally, the presence of emerging and high-growth markets across the region supports the adoption of urinalysis testing and diagnostic technologies.
The breakup of the profile of primary participants in the urinalysis market:
- By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
- By Designation: C-level Executives (27%), Directors (18%), and Other Designations (55%)
- By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
The key players in the urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health (US), Sysmex Corporation (Japan), Thermo Fisher Scientific, Inc.(US), Danaher Corporation (US), Abbott (US), Bio-Rad Laboratories, Inc. (US), QuidelOrtho Corporation (Japan), Waters Corporation (US), Arkray, Inc. (Japan), Acon Laboratories, Inc. (US), 77 Elektronika KFT (Hungary), URIT Medical Electronic Group Co. Ltd. (China), Shenzhen, Mindray Bio-Medical Electronics Co., Ltd. (China), DIRUI Industrial Co. Ltd. (China), Biobase Group (China), ERBA Mannheim (UK), Alphatech Scientific (Peru), Teco Diagnostics (US), Analyticon Biotechnologies GmbH (Germany), Hivis Medical Technology Co., Ltd. (China), High Technology Inc. (US), Agappe Diagnostic Ltd. (India), Dialab GmbH (Austria), Quantimetrix (US), Biocare Corporation (Taiwan), Randox Laboratories Ltd. (Ireland), PZ Cormay S.A. (Poland), YD Diagnostics (South Korea), Contec Medical Systems Co., Ltd. (China), and Clarity Diagnostics LLC (US).
Research Coverage:
The scope of the report covers detailed information on the major factors, such as drivers, restraints, opportunities, and challenges, that influence the growth of the urinalysis market. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, solutions, key strategies, acquisitions, and agreements. The report also covers new product launches and recent developments associated with the urinalysis market. Competitive analysis of upcoming startups in the urinalysis market ecosystem is included in this report.
Reasons to Buy this Report:
The report will assist market leaders and new entrants in the urinalysis industry by providing estimated revenue figures for the overall market and its subsegments. It aims to help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer, rising geriatric population and subsequent increase in age-associated diseases, and increasing adoption of PoC urine diagnostic tests), opportunities (growth opportunities in emerging countries, technological advancements in urine analyzers, and increasing government initiatives and funding for preventive care), restraints (availability of refurbished urine analyzers and high capital investments and lack of skilled laboratory technicians), and challenges (changing regulatory landscape) influencing the growth of the urinalysis market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urinalysis market
- Market Development: Comprehensive information about lucrative markets; the report analyzes the urinalysis market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), and Danaher (US).
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
- 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS SHAPING MARKET
- 2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS
- 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 URINALYSIS MARKET OVERVIEW
- 3.2 URINALYSIS MARKET, BY PRODUCT, 2026 VS. 2031
- 3.3 URINALYSIS MARKET, BY TEST TYPE, 2026 VS. 2031
- 3.4 URINALYSIS MARKET, BY APPLICATION, 2026 VS. 2031
- 3.5 URINALYSIS MARKET, BY TECHNOLOGY, 2026 VS. 2031
- 3.6 URINALYSIS MARKET, BY END USER, 2026 VS. 2031
- 3.7 URINALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
- 4.2.1.2 Rising geriatric population and subsequent increase in age-associated diseases
- 4.2.1.3 Increasing adoption of PoC urine diagnostic tests
- 4.2.2 RESTRAINTS
- 4.2.2.1 Availability of refurbished urine analyzers
- 4.2.2.2 High capital investments and lack of skilled laboratory technicians
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Growth opportunities in emerging countries
- 4.2.3.2 Technological advancements in urine analyzers
- 4.2.3.3 Increasing government initiatives and funding for preventive care
- 4.2.4 CHALLENGES
- 4.2.4.1 Changing regulatory landscape
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS IN URINALYSIS DIAGNOSTICS MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
- 4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 BARGAINING POWER OF SUPPLIERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 ECOSYSTEM ANALYSIS
- 5.5.1 URINALYSIS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE OF URINALYSIS, BY KEY PLAYER, 2024-2026
- 5.6.2 AVERAGE SELLING PRICE OF URINALYSIS BY REGION, 2024-2026
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT SCENARIO (HS CODE 3822)
- 5.7.2 EXPORT SCENARIO (HS CODE 3822)
- 5.8 KEY CONFERENCES & EVENTS, 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.10 INVESTMENT & FUNDING SCENARIO
- 5.11 IMPACT OF 2025 US TARIFF ON URINALYSIS MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON REGION
- 5.11.4.1 North America
- 5.11.4.2 Europe
- 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
- 5.11.5.1 Hospitals & Clinics
- 5.11.5.2 Home Care Settings
- 5.11.5.3 Diagnostic Laboratories
6 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 6.1 DECISION-MAKING PROCESS
- 6.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 6.2.2 BUYING CRITERIA
- 6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 6.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
- 6.5 MARKET PROFITABILITY
- 6.5.1 REVENUE POTENTIAL
- 6.5.2 COST DYNAMICS
- 6.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS/INDUSTRIES
7 REGULATORY LANDSCAPE AND SUSTAINABILITY
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN URINALYSIS
- 7.2.1.1 Eco-friendly Initiatives
- 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN URINALYSIS
- 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 8.1 KEY EMERGING TECHNOLOGIES
- 8.1.1 AUTOMATED URINE ANALYZERS
- 8.1.2 BIOCHEMICAL ASSAY
- 8.2 COMPLEMENTARY TECHNOLOGIES
- 8.2.1 POINT-OF-CARE URINE ANALYZERS
- 8.3 ADJACENT TECHNOLOGIES
- 8.3.1 MULTIPLEX PCR
- 8.4 TECHNOLOGY/PRODUCT ROADMAP
- 8.5 PATENT ANALYSIS
- 8.5.1 LIST OF KEY PATENTS
- 8.6 FUTURE APPLICATIONS
- 8.7 IMPACT OF AI/GENERATIVE AI ON THE URINALYSIS MARKET
- 8.7.1 INTRODUCTION
- 8.7.2 TOP USE CASES AND MARKET POTENTIAL
- 8.7.3 KEY COMPANIES IMPLEMENTING AI
- 8.7.4 FUTURE OF AI/GEN AI
9 URINALYSIS MARKET, BY PRODUCT
- 9.1 INTRODUCTION
- 9.2 CONSUMABLES
- 9.2.1 PREGNANCY & FERTILITY KITS
- 9.2.1.1 Rapid accessibility and testing convenience to drive market
- 9.2.2 DIPSTICKS
- 9.2.2.1 Low cost to increase adoption
- 9.2.3 REAGENTS
- 9.2.3.1 Increasing use of controls and calibrators to drive market
- 9.2.4 DISPOSABLES
- 9.2.4.1 Wise usage in hospitals and clinical laboratories to support market growth
- 9.2.1 PREGNANCY & FERTILITY KITS
- 9.3 INSTRUMENTS
- 9.3.1 AUTOMATED URINE ANALYZERS
- 9.3.1.1 Integrated urine analyzers
- 9.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
- 9.3.1.2 Sediment urine analyzers
- 9.3.1.2.1 Microscopy analyzers
- 9.3.1.2.1.1 Increased speed and accuracy of analysis to drive adoption
- 9.3.1.2.2 Flow cytometry analyzers
- 9.3.1.2.2.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
- 9.3.1.2.1 Microscopy analyzers
- 9.3.1.3 Biochemical urine analyzers
- 9.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
- 9.3.1.1 Integrated urine analyzers
- 9.3.2 SEMI-AUTOMATED URINE ANALYZERS
- 9.3.2.1 Extensive use in hospitals & clinics to drive segment growth
- 9.3.3 POINT-OF-CARE URINE ANALYZERS
- 9.3.3.1 Need for rapid testing to drive demand for PoC urine analyzers
- 9.3.1 AUTOMATED URINE ANALYZERS
10 URINALYSIS MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 DISEASE SCREENING
- 10.2.1 URINARY TRACT INFECTIONS
- 10.2.1.1 Increasing prevalence of UTIs to drive segment growth
- 10.2.2 KIDNEY DISEASES
- 10.2.2.1 Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth
- 10.2.3 DIABETES
- 10.2.3.1 Development of advanced analytical tools to drive market
- 10.2.4 LIVER DISEASES
- 10.2.4.1 High prevalence of liver diseases to support market growth
- 10.2.5 OTHER DISEASE SCREENING APPLICATIONS
- 10.2.1 URINARY TRACT INFECTIONS
- 10.3 PREGNANCY & FERTILITY TESTING
- 10.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
11 URINALYSIS MARKET, BY TEST TYPE
- 11.1 INTRODUCTION
- 11.2 PREGNANCY & FERTILITY TESTS
- 11.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET
- 11.3 BIOCHEMICAL TESTS
- 11.3.1 LABORATORY TESTS
- 11.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
- 11.3.2 POC TESTS
- 11.3.2.1 Convenience of PoC testing to drive segment growth
- 11.3.1 LABORATORY TESTS
- 11.4 SEDIMENT URINALYSIS
- 11.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET
12 URINALYSIS MARKET, BY TECHNOLOGY
- 12.1 INTRODUCTION
- 12.2 BIOCHEMICAL ASSAY
- 12.2.1 WIDESPREAD USE ACROSS DISEASE SCREENING AND HOME-BASED TESTING TO SUPPORT SEGMENT DOMINANCE
- 12.3 FLOW CYTOMETRY
- 12.3.1 RISING ADOPTION OF AUTOMATED SEDIMENT ANALYSIS TO DRIVE STEADY GROWTH
- 12.4 DIGITAL MICROSCOPY
- 12.4.1 GROWING PREFERENCE FOR AI-ASSISTED IMAGING TO ACCELERATE ADOPTION
- 12.5 OTHER TECHNOLOGIES
13 URINALYSIS MARKET, BY END USER
- 13.1 INTRODUCTION
- 13.2 DIAGNOSTIC LABORATORIES
- 13.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
- 13.3 HOSPITALS & CLINICS
- 13.3.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
- 13.4 HOME CARE SETTINGS
- 13.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
- 13.5 RESEARCH LABORATORIES & INSTITUTES
- 13.5.1 DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
14 URINALYSIS MARKET, BY REGION
- 14.1 INTRODUCTION
- 14.2 NORTH AMERICA
- 14.2.1 US
- 14.2.1.1 Rising prevalence of chronic diseases to drive market
- 14.2.2 CANADA
- 14.2.2.1 Rising burden of CKD to augment market
- 14.2.1 US
- 14.3 EUROPE
- 14.3.1 GERMANY
- 14.3.1.1 Increasing healthcare expenditure to fuel market growth
- 14.3.2 UK
- 14.3.2.1 Rising government healthcare expenditure to propel market
- 14.3.3 FRANCE
- 14.3.3.1 High R&D expenditure to provide growth opportunities
- 14.3.4 ITALY
- 14.3.4.1 Rising prevalence of diabetes to drive market
- 14.3.5 SPAIN
- 14.3.5.1 Growing elderly population to propel market
- 14.3.6 REST OF EUROPE
- 14.3.1 GERMANY
- 14.4 ASIA PACIFIC
- 14.4.1 CHINA
- 14.4.1.1 Improving healthcare infrastructure to support market growth
- 14.4.2 JAPAN
- 14.4.2.1 Favorable regulatory framework to drive market growth
- 14.4.3 INDIA
- 14.4.3.1 Increasing investments in healthcare system to drive market
- 14.4.4 AUSTRALIA
- 14.4.4.1 Rising prevalence of chronic diseases to propel market
- 14.4.5 SOUTH KOREA
- 14.4.5.1 Growing medical tourism to drive demand for urinalysis
- 14.4.6 REST OF ASIA PACIFIC
- 14.4.1 CHINA
- 14.5 LATIN AMERICA
- 14.5.1 BRAZIL
- 14.5.1.1 Largest healthcare market in Latin America
- 14.5.2 MEXICO
- 14.5.2.1 Popularity in medical tourism to drive market growth
- 14.5.3 REST OF LATIN AMERICA
- 14.5.1 BRAZIL
- 14.6 MIDDLE EAST & AFRICA
- 14.6.1 UAE
- 14.6.1.1 High diabetes prevalence to drive demand for urinalysis
- 14.6.2 SAUDI ARABIA
- 14.6.2.1 Rising diabetes burden to support market growth
- 14.6.3 REST OF MIDDLE EAST & AFRICA
- 14.6.1 UAE
15 COMPETITIVE LANDSCAPE
- 15.1 INTRODUCTION
- 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN URINALYSIS MARKET
- 15.3 REVENUE ANALYSIS, 2023-2025
- 15.4 MARKET SHARE ANALYSIS, 2025
- 15.4.1 GLOBAL MARKET SHARE ANALYSIS, 2025
- 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 15.5.1 STARS
- 15.5.2 EMERGING LEADERS
- 15.5.3 PERVASIVE PLAYERS
- 15.5.4 PARTICIPANTS
- 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 15.5.5.1 Company footprint
- 15.5.5.2 Region footprint
- 15.5.5.3 Product footprint
- 15.5.5.4 Application footprint
- 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 15.6.1 PROGRESSIVE COMPANIES
- 15.6.2 RESPONSIVE COMPANIES
- 15.6.3 DYNAMIC COMPANIES
- 15.6.4 STARTING BLOCKS
- 15.6.5 COMPANY FOOTPRINT: STARTUPS/SMES, 2025
- 15.6.5.1 Detailed list of key startups/SMEs
- 15.6.5.2 Competitive benchmarking of startups/SMEs, by product and application
- 15.6.5.3 Competitive benchmarking of startups/SMEs, by region
- 15.7 COMPANY VALUATION & FINANCIAL METRICS
- 15.7.1 FINANCIAL METRICS
- 15.7.2 COMPANY VALUATION
- 15.8 BRAND/PRODUCT COMPARISON
- 15.9 COMPETITIVE SCENARIO
- 15.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
- 15.9.2 DEALS
- 15.9.3 EXPANSIONS
16 COMPANY PROFILES
- 16.1 KEY PLAYERS
- 16.1.1 SIEMENS HEALTHINEERS AG
- 16.1.1.1 Business overview
- 16.1.1.2 Products offered
- 16.1.1.3 Recent developments
- 16.1.1.3.1 Product launches
- 16.1.1.3.2 Deals
- 16.1.1.3.3 Expansions
- 16.1.1.4 MnM view
- 16.1.1.4.1 Key strengths
- 16.1.1.4.2 Strategic choices
- 16.1.1.4.3 Weaknesses & competitive threats
- 16.1.2 F. HOFFMANN-LA ROCHE LTD
- 16.1.2.1 Business overview
- 16.1.2.2 Products offered
- 16.1.2.3 MnM view
- 16.1.2.3.1 Key strengths
- 16.1.2.3.2 Strategic choices
- 16.1.2.3.3 Weaknesses & competitive threats
- 16.1.3 SYSMEX CORPORATION
- 16.1.3.1 Business overview
- 16.1.3.2 Products offered
- 16.1.3.3 Recent developments
- 16.1.3.3.1 Product launches
- 16.1.3.3.2 Expansions
- 16.1.3.4 MnM view
- 16.1.3.4.1 Key strengths
- 16.1.3.4.2 Strategic choices
- 16.1.3.4.3 Weaknesses & competitive threats
- 16.1.4 DANAHER CORPORATION
- 16.1.4.1 Business overview
- 16.1.4.2 Products offered
- 16.1.4.3 Recent developments
- 16.1.4.3.1 Product launches
- 16.1.4.3.2 Deals
- 16.1.4.4 MnM view
- 16.1.4.4.1 Key strengths
- 16.1.4.4.2 Strategic choices
- 16.1.4.4.3 Weaknesses & competitive threats
- 16.1.5 ABBOTT
- 16.1.5.1 Business overview
- 16.1.5.2 Products offered
- 16.1.5.3 MnM view
- 16.1.5.3.1 Key strengths
- 16.1.5.3.2 Strategic choices
- 16.1.5.3.3 Weaknesses & competitive threats
- 16.1.6 CARDINAL HEALTH, INC.
- 16.1.6.1 Business overview
- 16.1.6.2 Products offered
- 16.1.6.3 Recent developments
- 16.1.6.3.1 Expansions
- 16.1.7 WATERS CORPORATION
- 16.1.7.1 Business overview
- 16.1.7.2 Products offered
- 16.1.7.3 Recent developments
- 16.1.7.3.1 Deals
- 16.1.8 THERMO FISHER SCIENTIFIC INC.
- 16.1.8.1 Business overview
- 16.1.8.2 Products offered
- 16.1.9 BIO-RAD LABORATORIES, INC.
- 16.1.9.1 Business overview
- 16.1.9.2 Products offered
- 16.1.10 QUIDELORTHO CORPORATION
- 16.1.10.1 Business overview
- 16.1.10.2 Products offered
- 16.1.1 SIEMENS HEALTHINEERS AG
- 16.2 OTHER PLAYERS
- 16.2.1 ARKRAY, INC.
- 16.2.2 ACON LABORATORIES, INC.
- 16.2.3 77 ELEKTRONIKA KFT.
- 16.2.4 URIT MEDICAL ELECTRONIC CO., LTD.
- 16.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
- 16.2.6 DIRUI INDUSTRIAL CO., LTD.
- 16.2.7 BIOBASE GROUP
- 16.2.8 ERBA MANNHEIM
- 16.2.9 ALPHATEC SCIENTIFIC E.I.R.L.
- 16.2.10 TECO DIAGNOSTICS
- 16.2.11 ANALYTICON BIOTECHNOLOGIES GMBH
- 16.2.12 HIVIS MEDICAL TECHNOLOGY CO., LTD.
- 16.2.13 HIGH TECHNOLOGY, INC.
- 16.2.14 AGAPPE DIAGNOSTICS LTD
- 16.2.15 DIALAB GMBH
- 16.2.16 QUANTIMETRIX
- 16.2.17 BIOCARE CORPORATION
- 16.2.18 RANDOX LABORATORIES LTD.
- 16.2.19 PZ CORMAY S.A.
- 16.2.20 YD DIAGNOSTICS
- 16.2.21 CONTEC MEDICAL SYSTEMS CO., LTD.
- 16.2.22 CLARITY DIAGNOSTICS, LLC
- 16.2.23 BIOPANDA REAGENTS LTD.
- 16.2.24 GENUINE BIOSYSTEM
17 RESEARCH METHODOLOGY
- 17.1 RESEARCH DATA
- 17.2 RESEARCH APPROACH
- 17.2.1 SECONDARY DATA
- 17.2.1.1 Key data from secondary sources
- 17.2.2 PRIMARY DATA
- 17.2.2.1 List of primary sources
- 17.2.2.2 Key data from primary sources
- 17.2.2.3 Key industry insights
- 17.2.2.4 Breakdown of primary interviews
- 17.2.1 SECONDARY DATA
- 17.3 MARKET SIZE ESTIMATION
- 17.3.1 TOTAL MARKET SIZE: URINALYSIS MARKET
- 17.3.2 BOTTOM-UP APPROACH
- 17.3.2.1 Approach 1: Company revenue estimation approach
- 17.3.2.2 Approach 2: Presentations of companies and primary interviews
- 17.3.2.3 Growth forecast
- 17.3.2.4 CAGR projections
- 17.3.3 TOP-DOWN APPROACH
- 17.4 DATA TRIANGULATION
- 17.5 RESEARCH ASSUMPTIONS
- 17.5.1 STUDY-RELATED ASSUMPTIONS
- 17.6 STUDY ASSUMPTIONS
- 17.6.1 PARAMETRIC ASSUMPTIONS
- 17.6.2 GROWTH RATE ASSUMPTIONS
- 17.7 RESEARCH LIMITATIONS
- 17.8 RISK ASSESSMENT
18 APPENDIX
- 18.1 DISCUSSION GUIDE
- 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 18.3 CUSTOMIZATION OPTIONS
- 18.4 RELATED REPORTS
- 18.5 AUTHOR DETAILS
List of Tables
- TABLE 1 AGE-STANDARDIZED PREVALENCE OF DIABETES, % BY REGION, 2024 VS. 2050
- TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2030 VS. 2050
- TABLE 3 URINALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 4 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023-2030
- TABLE 5 NORTH AMERICA: MACROECONOMIC INDICATORS
- TABLE 6 EUROPE: MACROECONOMIC INDICATORS
- TABLE 7 ASIA PACIFIC: MACROECONOMIC INDICATORS
- TABLE 8 LATIN AMERICA: MACROECONOMIC INDICATORS
- TABLE 9 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
- TABLE 10 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY KEY PLAYER, 2024-2026 (USD)
- TABLE 11 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION, 2024-2026 (USD)
- TABLE 12 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
- TABLE 13 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
- TABLE 14 URINALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2026-2027
- TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
- TABLE 17 KEY BUYING CRITERIA, BY PRODUCT
- TABLE 18 ADOPTION BARRIERS & INTERNAL CHALLENGES
- TABLE 19 URINALYSIS MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
- TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 25 KEY PATENTS IN URINALYSIS MARKET, 2023-2025
- TABLE 26 KEY COMPANIES IMPLEMENTING AI IN URINALYSIS MARKET
- TABLE 27 URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 28 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET
- TABLE 29 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 30 URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 31 NORTH AMERICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 32 EUROPE: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 33 ASIA PACIFIC: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 34 LATIN AMERICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 35 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET
- TABLE 37 URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 38 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 39 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 40 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 41 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 42 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 43 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET
- TABLE 44 URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 45 NORTH AMERICA: URINALYSIS MARKET FOR DIPSTICKS CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 EUROPE: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 ASIA PACIFIC: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 48 LATIN AMERICA: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 50 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET
- TABLE 51 URINALYSIS MARKET FOR REAGENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 52 NORTH AMERICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 EUROPE: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 ASIA PACIFIC: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 55 LATIN AMERICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 56 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 57 URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 58 NORTH AMERICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 EUROPE: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 ASIA PACIFIC: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 61 LATIN AMERICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 62 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET
- TABLE 64 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 65 URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 66 NORTH AMERICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 67 EUROPE: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 ASIA PACIFIC: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 69 LATIN AMERICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 70 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 71 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET
- TABLE 72 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 73 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 74 NORTH AMERICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 EUROPE: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 76 ASIA PACIFIC: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 LATIN AMERICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 78 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 79 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET
- TABLE 80 URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 81 NORTH AMERICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 EUROPE: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 83 ASIA PACIFIC: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 84 LATIN AMERICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 85 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 86 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET
- TABLE 87 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 88 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 89 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 90 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 91 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 92 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 93 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 94 URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 95 NORTH AMERICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 EUROPE: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 97 ASIA PACIFIC: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 98 LATIN AMERICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 99 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 100 URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 101 NORTH AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 102 EUROPE: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 103 ASIA PACIFIC: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 LATIN AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 105 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 106 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET
- TABLE 107 URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 108 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 110 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 112 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 113 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET
- TABLE 114 URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 115 NORTH AMERICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 EUROPE: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 117 ASIA PACIFIC: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 118 LATIN AMERICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 120 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET
- TABLE 121 URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 122 NORTH AMERICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 123 EUROPE: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 124 ASIA PACIFIC: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 LATIN AMERICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 127 URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 128 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 129 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 130 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 131 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 133 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 134 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 135 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 136 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 137 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 138 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 139 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 140 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 141 TOTAL GERIATRIC POPULATION, 2030 VS. 2050 (%)
- TABLE 142 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 143 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 144 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 145 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 146 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 147 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2024 VS. 2050 (IN MILLION)
- TABLE 149 URINALYSIS MARKET FOR DIABETES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 150 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 151 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 152 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 154 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 155 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 156 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 157 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 158 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 159 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 160 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 161 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 163 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 166 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 168 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 169 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 171 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 173 URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 174 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 175 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 176 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 178 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 179 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 180 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 181 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 182 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 183 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 185 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 186 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 187 KEY PRODUCTS IN LABORATORY TESTS MARKET
- TABLE 188 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 189 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 190 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 191 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 192 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 193 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 194 KEY PRODUCTS IN POC TESTS MARKET
- TABLE 195 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 196 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 197 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 199 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 200 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 201 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 202 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 203 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 204 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 205 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 206 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 207 URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 208 URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 209 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 210 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 211 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 212 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 213 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 214 URINALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 215 NORTH AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 216 EUROPE: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 217 ASIA PACIFIC: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 218 LATIN AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 219 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 220 URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 221 NORTH AMERICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 222 EUROPE: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 223 ASIA PACIFIC: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 224 LATIN AMERICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 225 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 226 URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 227 NORTH AMERICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 228 EUROPE: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 229 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 230 LATIN AMERICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 231 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 232 URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 233 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 234 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 235 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 236 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 237 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 238 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 239 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 240 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 241 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 242 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 243 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 244 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 245 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 246 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 247 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 248 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 250 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 251 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 252 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 253 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 254 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 255 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 256 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 257 URINALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 258 NORTH AMERICA: MACROECONOMIC INDICATORS
- TABLE 259 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 260 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 261 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 262 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 263 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 264 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 265 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 266 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 267 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 268 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 269 NORTH AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 270 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 271 US LABORATORY-BASED URINALYSIS TEST VOLUME, 2024-2031 (IN MN)
- TABLE 272 US: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 273 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 274 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 275 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 276 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 277 US: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 278 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 279 US: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 280 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 281 US: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 282 US: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 283 CANADA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 284 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 285 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 286 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 287 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 288 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 289 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 290 CANADA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 291 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 292 CANADA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 293 CANADA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 294 MACROECONOMIC INDICATORS FOR EUROPE
- TABLE 295 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 296 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 297 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 298 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 299 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 300 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 301 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 302 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 303 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 304 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 305 EUROPE: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 306 EUROPE: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 307 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 308 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 309 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 310 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 311 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 312 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 313 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 314 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 315 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 316 GERMANY: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 317 GERMANY: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 318 UK: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 319 UK: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 320 UK: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 321 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 322 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 323 UK: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 324 UK: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 325 UK: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 326 UK: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 327 UK: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 328 UK: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 329 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 330 FRANCE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 331 FRANCE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 332 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 333 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 334 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 335 FRANCE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 336 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 337 FRANCE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 338 FRANCE: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 339 FRANCE: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 340 ITALY: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 341 ITALY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 342 ITALY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 343 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 344 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 345 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 346 ITALY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 347 ITALY: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 348 ITALY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 349 ITALY: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 350 ITALY: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 351 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 352 SPAIN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 353 SPAIN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 354 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 355 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 356 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 357 SPAIN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 358 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 359 SPAIN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 360 SPAIN: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 361 SPAIN: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 362 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 363 REST OF EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 364 REST OF EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 365 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 366 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 367 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 368 REST OF EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 369 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 370 REST OF EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 371 REST OF EUROPE: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 372 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 373 MACROECONOMIC INDICATORS FOR ASIA PACIFIC
- TABLE 374 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 375 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 376 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 377 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 378 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 379 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 380 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 381 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 382 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 383 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 384 ASIA PACIFIC: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 385 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 386 CHINA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 387 CHINA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 388 CHINA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 389 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 390 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 391 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 392 CHINA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 393 CHINA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 394 CHINA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 395 CHINA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 396 CHINA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 397 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 398 JAPAN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 399 JAPAN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 400 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 401 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 402 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 403 JAPAN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 404 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 405 JAPAN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 406 JAPAN: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 407 JAPAN: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 408 INDIA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 409 INDIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 410 INDIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 411 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 412 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 413 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 414 INDIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 415 INDIA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 416 INDIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 417 INDIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 418 INDIA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 419 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 420 AUSTRALIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 421 AUSTRALIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 422 AUSTRALIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 423 AUSTRALIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 424 AUSTRALIA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 425 AUSTRALIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 426 AUSTRALIA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 427 AUSTRALIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 428 AUSTRALIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 429 AUSTRALIA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 430 SOUTH KOREA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 431 SOUTH KOREA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 432 SOUTH KOREA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 433 SOUTH KOREA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 434 SOUTH KOREA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 435 SOUTH KOREA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 436 SOUTH KOREA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 437 SOUTH KOREA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 438 SOUTH KOREA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 439 SOUTH KOREA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 440 SOUTH KOREA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 441 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 442 REST OF ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 443 REST OF ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 444 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 445 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 446 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 447 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 448 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 449 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 450 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 451 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 452 MACROECONOMIC INDICATORS FOR LATIN AMERICA
- TABLE 453 LATIN AMERICA: URINALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 454 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 455 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 456 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 457 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 458 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 459 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 460 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 461 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 462 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 463 LATIN AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 464 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 465 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 466 BRAZIL: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 467 BRAZIL: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 468 BRAZIL: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 469 BRAZIL: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 470 BRAZIL: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 471 BRAZIL: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 472 BRAZIL: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 473 BRAZIL: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 474 BRAZIL: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 475 BRAZIL: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 476 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 477 MEXICO: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 478 MEXICO: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 MEXICO: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 480 MEXICO: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 481 MEXICO: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 482 MEXICO: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 483 MEXICO: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 484 MEXICO: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 485 MEXICO: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 486 MEXICO: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 487 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 488 REST OF LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 489 REST OF LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 490 REST OF LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 491 REST OF LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 492 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 493 REST OF LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 494 REST OF LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 495 REST OF LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 496 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 497 REST OF LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 498 MACROECONOMIC INDICATORS FOR MIDDLE EAST & AFRICA
- TABLE 499 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 500 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 501 MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 502 MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 503 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 504 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 505 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 506 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 507 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 508 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 509 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 510 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 511 UAE: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 512 UAE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 513 UAE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 514 UAE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 515 UAE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 516 UAE: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 517 UAE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 518 UAE: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 519 UAE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 520 UAE: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 521 UAE: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 522 SAUDI ARABIA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 523 SAUDI ARABIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 524 SAUDI ARABIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 525 SAUDI ARABIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 526 SAUDI ARABIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 527 SAUDI ARABIA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 528 SAUDI ARABIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 529 SAUDI ARABIA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 530 SAUDI ARABIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 531 SAUDI ARABIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 532 SAUDI ARABIA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 533 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 534 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 535 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 536 EST OF THE MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 537 REST OF THE MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 539 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 541 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 542 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 543 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 544 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN URINALYSIS MARKET, JANUARY 2023-JULY 2026
- TABLE 545 URINALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 546 URINALYSIS MARKET: REGION FOOTPRINT
- TABLE 547 URINALYSIS MARKET: PRODUCT FOOTPRINT
- TABLE 548 URINALYSIS MARKET: APPLICATION FOOTPRINT
- TABLE 549 URINALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
- TABLE 550 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT AND APPLICATION
- TABLE 551 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
- TABLE 552 URINALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023- JULY 2026
- TABLE 553 URINALYSIS MARKET: DEALS, JANUARY 2023- JULY 2026
- TABLE 554 URINALYSIS MARKET: EXPANSION, JANUARY 2023- JULY 2026
- TABLE 555 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
- TABLE 556 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
- TABLE 557 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
- TABLE 558 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023-JULY 2026
- TABLE 559 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 560 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW
- TABLE 561 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
- TABLE 562 SYSMEX CORPORATION: COMPANY OVERVIEW
- TABLE 563 SYSMEX CORPORATION: PRODUCTS OFFERED
- TABLE 564 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
- TABLE 565 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 566 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 567 DANAHER CORPORATION: PRODUCTS OFFERED
- TABLE 568 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
- TABLE 569 DANAHER CORPORATION: DEALS, JANUARY 2023-JULY 2026
- TABLE 570 ABBOTT: COMPANY OVERVIEW
- TABLE 571 ABBOTT: PRODUCTS OFFERED
- TABLE 572 CARDINAL HEALTH, INC.: COMPANY OVERVIEW
- TABLE 573 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
- TABLE 574 CARDINAL HEALTH, INC.: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 575 WATERS CORPORATION: COMPANY OVERVIEW
- TABLE 576 WATERS CORPORATION: PRODUCTS OFFERED
- TABLE 577 WATERS CORPORATION: DEALS, JANUARY 2023-JULY 2026
- TABLE 578 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 579 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
- TABLE 580 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 581 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
- TABLE 582 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
- TABLE 583 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
- TABLE 584 URINALYSIS MARKET: RISK ASSESSMENT
List of Figures
- FIGURE 1 URINALYSIS MARKET SEGMENTATION
- FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
- FIGURE 3 GLOBAL URINALYSIS MARKET, 2024-2031
- FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN URINALYSIS MARKET, 2023-2025
- FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF URINALYSIS MARKET
- FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN URINALYSIS MARKET, 2025
- FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 8 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
- FIGURE 9 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS MARKET
- FIGURE 10 BIOCHEMICAL TESTS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 11 DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 12 BIOCHEMICAL ASSAY SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 13 DIAGNOSTIC LABORATORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 15 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 16 URINALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 17 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 18 URINALYSIS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 19 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 20 URINALYSIS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 21 NUMBER OF DEALS & FUNDING ACTIVITIES IN URINALYSIS MARKET
- FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
- FIGURE 23 KEY BUYING CRITERIA, BY PRODUCT
- FIGURE 24 PATENT ANALYSIS FOR URINALYSIS, JANUARY 2016-DECEMBER 2025
- FIGURE 25 MARKET POTENTIAL OF AI IN URINALYSIS MARKET
- FIGURE 26 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
- FIGURE 27 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
- FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET, 2023-2025 (USD MILLION)
- FIGURE 29 URINALYSIS MARKET SHARE ANALYSIS, 2025 (GLOBAL)
- FIGURE 30 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 31 URINALYSIS MARKET: COMPANY FOOTPRINT
- FIGURE 32 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 33 EV/EBITDA OF KEY VENDORS
- FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 35 URINALYSIS MARKET: BRAND/PRODUCT COMPARISON FOR URINE ANALYZERS
- FIGURE 36 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
- FIGURE 37 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2025)
- FIGURE 38 SYSMEX CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 40 ABBOTT: COMPANY SNAPSHOT (2025)
- FIGURE 41 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 42 WATERS CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 45 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 46 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY
- FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 48 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
- FIGURE 49 URINALYSIS MARKET: TOP-DOWN APPROACH
- FIGURE 50 DATA TRIANGULATION METHODOLOGY
02-2729-4219
+886-2-2729-4219
尿液檢查：市場佔有率分析、產業趨勢和統計數據、成長預測（2026-2031）
尿液檢查市場：2026-2032年全球市場預測（依產品類型、檢測類型、技術、應用、最終用戶及通路分類）
2026 年至 2035 年尿液檢查的市場機會、成長要素、產業趨勢分析與預測。
尿液檢查市場：依產品類型、檢測類型、應用和地區分類
全球尿液檢查市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
尿液尿液檢查市場規模、佔有率和成長分析：按檢測類型、應用、最終用戶、分銷管道、地區和行業預測，2026-2033年
獸用尿液檢查產品市場規模、佔有率和成長分析：按產品類型、動物種類、應用、最終用戶、銷售管道和地區分類 - 2026-2033 年行業預測
尿液檢查市場規模、佔有率和成長分析（按檢測方法、應用、最終用戶和地區分類）—產業預測（2026-2033 年）
尿液檢查市場規模、佔有率和成長分析（按產品類型、檢測類型、應用、最終用戶和地區分類）－2026-2033年產業預測
尿液分析儀：全球市佔率及排名、總收入及需求預測（2025-2031年）
▼